Paul K Gorecki
Biographic Data
| ID | 6471075 |
|---|---|
| NAME | Paul K Gorecki |
| GIVEN NAMES | Paul K |
| FAMILY NAME | Gorecki |
| SIGNATURE | GORECKI P K |
| AFFILIATIONS | Economic and Social Research Institute |
| ORCID | 0000-0002-6028-0193 |
| VERIFIED | Yes |
| TOTAL WORKS | 15 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 15 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1974 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 2 |
Public policy towards the sale of state assets in troubled times
Controlling Drug Expenditure in Canada
Structural Change and the Adjustment Process
Mergers, Corporate Concentration and Power in Canada
Distance and Duties
The Determinants of Small Plant Market Share in Canadian Manufacturing Industries in the 1970s
John R. Baldwin, Paul K. Gorecki, The Determinants of Small Plant Market Share in Canadian Manufacturing Industries in the 1970s, The Review of Economics and Statistics, Vol. 67, No. 1 (Feb., 1985), pp. 156-161
Compulsory Licensing of Drug Patents
James J. McRae, Francis Tapon, P. K. Gorecki, Douglas G. Hartle, Compulsory Licensing of Drug Patents: Three Comments, Canadian Public Policy / Analyse de Politiques, Vol. 10, No. 1 (Mar., 1984), pp. 74-87
The Impact of the Parcost Program on Prescription Drug Prices in Ontario
The Drug Industry
Regulating the Price of Prescription Drugs in Canada
Compulsory Patent Licensing of Drugs in Canada
In 1969 the Patent Act was amended to permit the issuance of licences to import patented drugs. The Pharmaceutical Manufacturers Association of Canada argues that this change has had a minimal impact on retail drug prices while adversely affecting R & D and the balance of trade. A Department of Industry, Trade and Commerce discussion paper released in 1980 on compulsory licensing takes almost the same position as the PMAC. It presents neither ind…
Federalism and the Regulatory Process
Economies of Scale and Efficient Plant Size in Canadian Manufacturing Industries
The Determinants of Entry by Domestic and Foreign Enterprises in Canadian Manufacturing Industries
Paul K. Gorecki, The Determinants of Entry by Domestic and Foreign Enterprises in Canadian Manufacturing Industries: Some Comments and Empirical Results, The Review of Economics and Statistics, Vol. 58, No. 4 (Nov., 1976), pp. 485-488
The Measurement of Enterprise Diversification
The Measurement of Enterprise Diversification
The Determinants of Entry by Domestic and Foreign Enterprises in Canadian Manufacturing Industries
Paul K. Gorecki, The Determinants of Entry by Domestic and Foreign Enterprises in Canadian Manufacturing Industries: Some Comments and Empirical Results, The Review of Economics and Statistics, Vol. 58, No. 4 (Nov., 1976), pp. 485-488
Economies of Scale and Efficient Plant Size in Canadian Manufacturing Industries
Federalism and the Regulatory Process
Compulsory Patent Licensing of Drugs in Canada
In 1969 the Patent Act was amended to permit the issuance of licences to import patented drugs. The Pharmaceutical Manufacturers Association of Canada argues that this change has had a minimal impact on retail drug prices while adversely affecting R & D and the balance of trade. A Department of Industry, Trade and Commerce discussion paper released in 1980 on compulsory licensing takes almost the same position as the PMAC. It presents neither ind…
The Impact of the Parcost Program on Prescription Drug Prices in Ontario
The Drug Industry
Regulating the Price of Prescription Drugs in Canada
Compulsory Licensing of Drug Patents
James J. McRae, Francis Tapon, P. K. Gorecki, Douglas G. Hartle, Compulsory Licensing of Drug Patents: Three Comments, Canadian Public Policy / Analyse de Politiques, Vol. 10, No. 1 (Mar., 1984), pp. 74-87
The Determinants of Small Plant Market Share in Canadian Manufacturing Industries in the 1970s
John R. Baldwin, Paul K. Gorecki, The Determinants of Small Plant Market Share in Canadian Manufacturing Industries in the 1970s, The Review of Economics and Statistics, Vol. 67, No. 1 (Feb., 1985), pp. 156-161
Distance and Duties
Mergers, Corporate Concentration and Power in Canada
Structural Change and the Adjustment Process
Controlling Drug Expenditure in Canada
Public policy towards the sale of state assets in troubled times
Business (14 works) · Economics (10 works) · Pharmaceutical Economics and Policy (6 works) · Industrial organization (5 works) · Medicine (5 works) · Pharmacology (5 works) · Drug (4 works) · Marketing (4 works) · Computer Science (3 works) · Firm Innovation and Growth (3 works)